3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
5
Stomach Neoplasms
1
Sarcoma, Ewing
1
Sarcoma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neoplasms
1
Neoplasm Metastasis
1
Endometrial Neoplasms
1
Desmoid Tumors
1
Craniopharyngioma
1
Colorectal Cancer Metastatic
1
Colonic Neoplasms
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Anal Cancer Metastatic
1
Adenomatous Polyposis Coli
1
Interventions
Nivolumab
22
Specimen Handling
17
pembrolizumab
13
cabozantinib
13
Magnetic Resonance Spectroscopy
13
belzutifan
12
Ipilimumab
12
lenvatinib
7
Axitinib
7
CTLA-4 Antigen
6
Biopsy
6
atezolizumab
4
Sunitinib
4
tivozanib
3
Surveys and Questionnaires
3
Immunoglobulin G
3
Everolimus
3
Disulfides
3
relatlimab
2
pazopanib
2
palbociclib
2
aldesleukin
2
Watchful Waiting
2
Standard of Care
2
Radiosurgery
2
Practice Guidelines as Topic
2
Nephrectomy
2
Bevacizumab
2
zimberelimab
1
ulixertinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Renal Cell
×
trifluridine tipiracil drug combination
×
30 days
×
Clear all
No trials found.